Таиландта таргеттік терапияның құны Bookimed деректері бойынша $7,000 / 238,000฿-ден $13,000 / 442,000฿-ге дейін тұрады. Орташа курс бағасы $10,000 / 340,000฿. Баға препараттың түріне (мысалы, тирозинкиназа ингибиторлары, моноклоналды антиденелер), курстың ұзақтығына, дозасына және аурудың сатысына байланысты. Қосымша анализдер мен мамандардың кеңесі де құнға әсер етеді.
Таиландта бағаға әдетте онкологтың кеңесі, емдеу схемасын таңдау, таргеттік препараттардың өзі, зертханалық бақылау, дәрігердің бақылауы және қолдаушы терапия кіреді. Кейде госпитализация мен қосымша тексерулер төленеді. Әрқашан бағаға анализдер, генетикалық тесттер және қолдаушы дәрілер кіретінін нақтылау қажет — бұл клиника мен терапия схемасына байланысты.
| Таиланд | Түркия | Австрия | |
| Мақсатты терапия | бастап $7,000 / 238,000฿ | бастап $1,000 / 34,000฿ | бастап $12,000 / 408,000฿ |
| Лютеций-177-пен емдеу | бастап $12,000 / 408,000฿ | бастап $8,800 / 299,200฿ | бастап $35,000 / 1,190,000฿ |
| Актиний-225 терапиясы | бастап $25,000 / 850,000฿ | бастап $22,955 / 780,470฿ | бастап $55,000 / 1,870,000฿ |
| Онкотермия | бастап $3,600 / 122,400฿ | - | - |
Сіз Bookimed қызметтері үшін төлемейсіз. Сайттағы мақсатты терапияны бағалары клиниканың баға тізіміне сәйкес келеді. Сіз жеткенде тікелей клиникада төлейсіз. Бөліктермен төлеу қолжетімді.
Bookimed Сіздің қауіпсіздігіңізді қамтамасыз етеді. Біз тек мақсатты терапияның жүргізу үшін жоғары халықаралық стандарттарға сәйкес келетін клиникалармен ғана жұмыс істейміз. Олардың бүкіл әлем бойынша халықаралық науқастарға қызмет көрсету үшін қажетті лицензиялары бар.
Bookimed тегін көмек және қолдау ұсынады. Жеке медициналық координатор сапарға дейін, кезінде және кейін Сізбен байланыста. Мақсатты терапия процедурасы кезінде Сіз басқа елде жалғыз қалмайсыз.
Top-tier hospitals for targeted therapy in Thailand include Bumrungrad International and Wattanosoth Cancer Hospital, which offer precision oncology and genetic profiling. These JCI-accredited facilities provide advanced treatments like Lutetium-177 and Actinium-225 therapy, often saving patients 75% compared to US medical costs.
Bookimed Expert Insight: While many top Thai hospitals offer standard targeted drugs, clinics like Panacee Hospital Rama 2 combine these with integrative therapies like cell rejuvenation. This multimodal approach is a unique regional trend. Patients should verify if their specific genomic markers (NGS, PD-L1) are recognized locally before travel.
Patient Consensus: Patients value the English-fluent oncologists and modern facilities but recommend booking 3 weeks ahead during peak seasons. Most suggest carrying physical pathology slides and digital imaging to ensure seamless care coordination after returning home.
Thailand manufactures targeted cancer drugs domestically. In 2025, the country launched its first two locally produced therapies, Imcranib 100 for leukemia and GIST, and Herdara, a biosimilar for breast cancer. These treatments are produced at the international GMP PIC/S certified Royal Pharmaceutical Manufacturing Plant.
Bookimed Expert Insight: Thai medical facilities like Bumrungrad International Hospital manage over 1 million patients annually. Their high volume allows them to maintain stable supplies of these domestic generics. Choosing these locally made versions can save you up to 75% compared to US costs.
Patient Consensus: Patients value the significant cost savings provided by Thai-manufactured generics like imatinib. Most recommend verifying drug origins via the Thai FDA app to ensure medication authenticity during treatment.
Targeted therapy uses precision medicine to attack specific genetic mutations or proteins like HER2 and EGFR, whereas chemotherapy broadens its impact by killing all rapidly dividing cells. Targeted drugs act as a cytostatic sniper to block cell multiplication, while cytotoxic chemotherapy acts as a systemic hammer affecting hair, gut, and blood cells.
Bookimed Expert Insight: Thailand's top facilities like JCI-accredited Bumrungrad International Hospital manage over 1 million patients annually with high-tech diagnostic integration. Our data shows patients often save significantly by accessing off-patent targeted drugs like imatinib in Bangkok. These generic options provide the same molecular precision as US brands at a fraction of the cost.
Patient Consensus: Many patients describe targeted therapy as a smart bomb that preserves their quality of life. They report significantly less fatigue and neuropathy compared to the brutal but universal experience of traditional chemotherapy cycles.
Before starting targeted therapy in Thailand, you should identify your specific genetic mutation and the treatment goals. Ask about administration methods, potential side effects like skin toxicity, and monitoring frequency. Clarify the total costs and available alternatives like immunotherapy within JCI-accredited facilities in Bangkok.
Bookimed Expert Insight: Patients often overlook that top Thai centers like Bumrungrad International Hospital serve over 500,000 international travelers annually. This high volume means their oncologists frequently use off-label combinations or advanced therapies like Actinium-225. Always ask your doctor if they have experience with your specific mutation in patients of your same ethnicity.
Patient Consensus: Patients emphasize recording consultations because technical details about progression-free survival are easily forgotten. Many recommend tracking daily side effects from day 1 to ensure early dose adjustments by the medical team.
International patients receive comprehensive travel and logistics support through dedicated Global Patient Services departments in Thailand. Major centers like Bumrungrad International Hospital facilitate medical visas, airport transfers, and local accommodations. These facilities often manage requirements for over 190 countries, ensuring seamless transitions for complex cancer treatments.
Bookimed Expert Insight: While many countries offer basic logistics, Thai hospitals like Bumrungrad International Hospital operate like high-end hotels. They manage nearly 500,000 international patients annually with dedicated wings for specific nationalities. This volume allows them to offer niche services like embassy coordination and specialized `one-stop` oncology packages that include post-discharge follow-up via telemedicine.
Patient Consensus: Patients value the `one-stop` convenience of airport pickups and SIM cards provided upon arrival. Most recommend confirming visa support and medication export rules before flying to avoid local stay limits.